Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Heldebrant

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Series Haematologica (1968)|January 1, 1973
Intermediates of prothrombin activationK G Mann, S P Bajaj, C M Heldebrant, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1993
Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safetyS W Herring, C Abildgaard, K T Shitanishi, et al.
Thrombosis and Haemostasis|June 28, 1990
The fibrinolytic potential of the normal primate following the generation of thrombin in vivoA R Giles, M E Nesheim, S W Herring, et al.
The Journal of Clinical Investigation|August 1, 1985
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factorJ S McDougal, L S Martin, S P Cort, et al.
Transfusion|November 1, 1985
Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Series Haematologica (1968)|January 1, 1973
Intermediates of prothrombin activationK G Mann, S P Bajaj, C M Heldebrant, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1993
Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safetyS W Herring, C Abildgaard, K T Shitanishi, et al.
Thrombosis and Haemostasis|June 28, 1990
The fibrinolytic potential of the normal primate following the generation of thrombin in vivoA R Giles, M E Nesheim, S W Herring, et al.
The Journal of Clinical Investigation|August 1, 1985
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factorJ S McDougal, L S Martin, S P Cort, et al.
Transfusion|November 1, 1985
Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.
Pageof 2